Clinical Trial Update: To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and tolerability of a fixed-dose combination of obeticholic acid and bezafibrate in primary biliary cholangitis has been ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Bezafibrate (bezafibrate)
• Obeticholic acid (obeticholic acid)

Snippet

Sponsor: Intercept Pharmaceuticals | Conditions: Primary Biliary Cholangitis | Phase 3 | Status: TERMINATED